Novo Nordisk Revenue 2010-2024 | NVO

Novo Nordisk revenue for the twelve months ending September 30, 2024 was $39.373B, a 27.63% increase year-over-year.

  • Novo Nordisk annual revenue for 2023 was $33.724B, a 34.59% increase from 2022.
  • Novo Nordisk annual revenue for 2022 was $25.057B, a 11.85% increase from 2021.
  • Novo Nordisk annual revenue for 2021 was $22.401B, a 15.18% increase from 2020.

Novo Nordisk Revenue 2010-2024 | NVO

  • Novo Nordisk annual revenue for 2023 was $33.724B, a 34.59% increase from 2022.
  • Novo Nordisk annual revenue for 2022 was $25.057B, a 11.85% increase from 2021.
  • Novo Nordisk annual revenue for 2021 was $22.401B, a 15.18% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B